Search

everythinglearnresearchcommunity

for

Search:↓

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

miRNA-24 affects goat coat color by controlling proteins involved in pigment production.

Blocking mTORC1 reduces skin tumor growth in mice.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Certain blood miRNAs are linked to severe alopecia areata and could lead to new treatments.

MK-386 reduces sebum DHT levels.

Certain miRNAs may influence cashmere fiber traits in goats by affecting hair follicle activities.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

PP405 shows promise as a new, effective treatment for hair loss with minimal side effects.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Probe detects finasteride with high selectivity and low detection limit.

Non-coding RNAs help control hair growth in cashmere goats.

DcR3 helps heal wounds and regrow hair by changing macrophages to a repair-focused type.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Non-coding RNAs may be key in diagnosing and treating rare skin disorders.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.